Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis
about
Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial ResistanceRole of Bacterioferritin & Ferritin in M. tuberculosis Pathogenesis and Drug Resistance: A Future Perspective by Interactomic Approach.Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates.Matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosisUsing a Label Free Quantitative Proteomics Approach to Identify Changes in Protein Abundance in Multidrug-Resistant Mycobacterium tuberculosis.Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant.Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography.Resistome analysis of Mycobacterium tuberculosis: Identification of aminoglycoside 2'-Nacetyltransferase (AAC) as co-target for drug desigining.Comparative Proteomic Analyses of Avirulent, Virulent, and Clinical Strains of Mycobacterium tuberculosis Identify Strain-specific PatternsProteomics Analysis of Three Different Strains of Mycobacterium tuberculosis under In vitro Hypoxia and Evaluation of Hypoxia Associated Antigen's Specific Memory T Cells in Healthy Household Contacts.M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance.Drug resistance to Mycobacterium tuberculosis: from the traditional Chinese view to modern systems biology.Proteomic profile of Mycobacterium tuberculosis after eupomatenoid-5 induction reveals potential drug targets.Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect.
P2860
Q26749601-1ABDBBF5-366E-4C1F-811F-849075305ABCQ33774550-CD33D751-0BEF-4C87-B78A-E1DCE9E2993DQ34178610-DD1C4B36-1FAE-469D-B345-6675F651D53DQ34538888-833B5598-23EB-48D3-814E-33D47A3B1D41Q35186976-78781F50-6A4A-4C5F-B973-FEBC6454FBE4Q35520252-AD50F30F-DDA0-4A95-A2F3-362A0EFC5BD3Q36078099-25A10389-64E3-43E4-A4C3-62648BBF156AQ36700497-51889E3A-0367-4EE2-AA81-B9862A7626BFQ37065764-3F9299C6-A298-4B34-BFD6-F5061D88B615Q37244389-EC3BA30F-9B3A-4DAB-B717-E121510404B9Q37712559-C5DA2130-41E5-4784-8C79-4CDF399D167DQ38179033-343E7F33-CB24-4B3B-93D8-85BE48A72AAEQ38661355-4F1EB57A-20C3-408F-8EF4-ADC3B0275C5BQ47366978-FB675278-C32C-4AB2-885E-BBBBE31D8461Q47429675-919B1515-4E86-424A-A46A-B31D488F2DA3Q55616387-AF30EFF7-98AD-4FD3-B649-01E68A12D9E6
P2860
Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteomic analysis of streptom ...... of Mycobacterium tuberculosis
@ast
Proteomic analysis of streptom ...... of Mycobacterium tuberculosis
@en
type
label
Proteomic analysis of streptom ...... of Mycobacterium tuberculosis
@ast
Proteomic analysis of streptom ...... of Mycobacterium tuberculosis
@en
prefLabel
Proteomic analysis of streptom ...... of Mycobacterium tuberculosis
@ast
Proteomic analysis of streptom ...... of Mycobacterium tuberculosis
@en
P2093
P2860
P356
P1433
P1476
Proteomic analysis of streptom ...... of Mycobacterium tuberculosis
@en
P2093
Bhavnesh Kumar
Deepa Bisht
Krishnamurthy Venkatesan
Neelja Singhal
Prashant Sharma
Vishwa Mohan Katoch
Yash Gupta
P2860
P2888
P356
10.1186/1477-5956-8-59
P577
2010-11-18T00:00:00Z
P5875
P6179
1006625775